Live Breaking News & Updates on Alternative Med

Stay updated with breaking news from Alternative med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

European Commission Approves First Tocilizumab Biosimilar

The biosimilar, commercially called Tyenne, is indicated to treat several autoimmune diseases as well as cytokine release syndrome and COVID-19. ....

Fresenius Kabi , Pierluigi Antonelli , Drug Administration , European Medicines Agency , European Commission , European Union , Chief Executive Officer Pierluigi Antonelli , Biologic License Application , Rheumatoid Arthritis , Biologic Therapy , Biosimilar Drugs , Follow On Biologics , Interleukin Antagonist , L Antagonist , Covid 19 Treatment , Juvenile Rheumatoid Arthritis , Oint Inflammation , Chimeric Antigen Receptort Cell Therapy , Chimeric Antigen Receptors , Himeric Immunoreceptors , Himerict Cell Receptors , Rtificialt Cell Receptors , Ar T , Alternative Med ,